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ABSTRACT
The Gene Ontology (GO) project (http://www.
geneontology.org) develops and uses a set of struc-
tured, controlled vocabularies for community use
in annotating genes, gene products and sequen-
ces (also see http://song.sourceforge.net/). The GO
Consortium continues to improve to the vocabulary
content, reflecting the impact of several novel mech-
anisms of incorporating community input. A growing
number of model organism databases and genome
annotation groups contribute annotation sets using
GO terms to GO’s public repository. Updates to the
AmiGObrowser have improvedaccess to contributed
genome annotations. As the GO project continues to
grow, the use of the GO vocabularies is becoming
more varied as well as more widespread. The GO pro-
ject provides an ontological annotation system that
enables biologists to infer knowledge from large
amounts of data.
INTRODUCTION
The Gene Ontology (GO) project (http://www.geneontology.
org) is a collaborative effort to construct and use ontologies
to facilitate the biologically meaningful annotation of genes
and their products in a wide variety of organisms. Groups
participating in the project include the major model organism
databases and other bioinformatics resource centers.
The GO Ontologies provide a systematic language, or onto-
logy (1–4), for the description of attributes of genes and gene
products, in three key domains that are shared by all organ-
isms, namely molecular function, biological process and cel-
lular component (5–10); sequence features are covered by the
Sequence Ontology, maintained separately from the GO onto-
logies (11).
The GO annotations have proven to be remarkably useful
for the mining of functional and biological significance from
very large datasets, such as microarray results. The GO also
facilitates the organization of data from novel, as well as fully
annotated, genomes and the comparison of biological infor-
mation between clade members and across clades.
IMPROVEMENTS IN GO CONTENT
From its inception, the GO project has developed its onto-
logies for the purpose of gene product annotation. To this end,
the Gene Ontology is dynamic: existing terms and relation-
ships are augmented, refined and reorganized as the current
state of biological knowledge advances. Major improvements
have been made over the past 2 years in several areas of
the ontology, often in consultation with experts in relevant
subject areas. The Plant-Associated Microbe Gene Ontology
(PAMGO) Interest Group collaborated with the GO Consor-
tium to produce a new set of terms representing pathogenic
and symbiotic processes (also see below). With help from
Correspondence should be addressed to GO-EBI, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. Tel: +44 0 1223 494667;
Fax: +44 0 1223 494468; Email: midori@ebi.ac.uk
*The current members of the GO Consortium are: Midori A. Harris, Jennifer I. Clark, Amelia Ireland, Jane Lomax (GO-EBI, Hinxton, UK); Michael Ashburner,
Russell Collins (FlyBase, Department of Genetics, University of Cambridge, Cambridge, UK); Karen Eilbeck, Suzanna Lewis, Chris Mungall, John Richter, Gerald
M. Rubin, ShengQiang Shu (BDGP, UC-Berkeley, Berkeley, CA, USA), Judith A. Blake, Carol J. Bult, Alexander D. Diehl, Mary E. Dolan, Harold J. Drabkin,
Janan T. Eppig, David P. Hill, Li Ni, Martin Ringwald (MGI, The Jackson Laboratory, Bar Harbor, ME, USA); Rama Balakrishnan, Gail Binkley, J. Michael
Cherry, Karen R. Christie, Maria C. Costanzo, Qing Dong, Stacia R. Engel, Dianna G. Fisk, Jodi E. Hirschman, Benjamin C. Hitz, Eurie L. Hong, Christopher Lane,
Stuart Miyasato, Robert Nash, Anand Sethuraman, Marek Skrzypek, Chandra L. Theesfeld, Shuai Weng (SGD, Department of Genetics, Stanford University,
Stanford, CA, USA); David Botstein, Kara Dolinski, Rose Oughtred (Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA);
Tanya Berardini, Suparna Mundodi, Seung Y. Rhee (TAIR, Carnegie Institution, Department of Plant Biology, Stanford, CA, USA); Rolf Apweiler, Daniel Barrell,
Evelyn Camon, Emily Dimmer, Nicola Mulder (GOA Database, UniProt, EBI, Hinxton, UK); Rex Chisholm, Petra Fey, Pascale Gaudet, Warren Kibbe, Karen
Pilcher (DictyBase, Northwestern University, Chicago, IL, USA); Carol A. Bastiani, Ranjana Kishore, Erich M. Schwarz, Paul Sternberg, Kimberly Van Auken
(WormBase, California Institute of Technology, Pasadena, CA, USA); Michelle Gwinn, Linda Hannick, Jennifer Wortman (The Institute for Genome Research,
Rockville, MD, USA); Martin Aslett, Matthew Berriman, Valerie Wood (Wellcome Trust Sanger Institute, Hinxton, UK); Susan Bromberg, Cindy Foote, Howard
Jacob, Dean Pasko, Victoria Petri, Dorothy Reilly, Kathy Seiler, Mary Shimoyama, Jennifer Smith, Simon Twigger (RGD, Medical College of Wisconsin,
Milwaukee, WI, USA); Pankaj Jaiswal (Gramene, Department of Plant Breeding, Cornell University, Ithaca, NY, USA); Trent Seigfried (MaizeGDB, Iowa State
University, Ames, IA, USA); Candace Collmer (Wells College, Aurora, NY, USA); Doug Howe, Monte Westerfield (ZFIN, University of Oregon, Eugene,
OR, USA).
 The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
D322–D326 Nucleic Acids Research, 2006, Vol. 34, Database issue
doi:10.1093/nar/gkj021
representatives of the BioCyc databases, the GO represen-
tation of metabolism was split into cellular and organismal
processes. The cell cycle node was extensively reworked and
is undergoing further improvement. Finally, high level terms
were added to the cellular component ontology to better
categorize terms representing the constituents of cells. A sum-
mary of the current ontology content is shown in Table 1.
MANAGING CONTENT CHANGES
All changes to the ontologies are centrally coordinated by the
GO Editorial Office (located at the European Bioinformatics
Institute, Hinxton, UK). Changes are proposed by GO curat-
ors, model organism database annotators and other interested
parties throughout the biological community. GO curators
have adapted the online tracking system provided by Source-
Forge to document progress (see http://geneontology.
sourceforge.net/); as of September 1, 2005, over 2800 items
have been posted, of which over 2100 have led to changes in
the ontologies.
The model organism database curators who use GO terms
intensively for gene product annotation play a key role in
guiding the development of GO. To complement their
input, the GO Consortium strives to involve members of
the biological research community in the ontology develop-
ment process. Experts in various biomedical fields provide
thorough, detailed knowledge of their particular topics that
complements GO curators’ understanding of existing GO
structures and conventions.
To promote communication among these various contrib-
utors and ensure consistency within the ontology, the GO
Consortium has established Curator Interest Groups and has
initiated a series of meetings devoted to ontology content; both
provide mechanisms to focus on areas within the ontologies
that are likely to require extensive additions or revisions.
Curator Interest Group membership is open not only to Con-
sortium members, but also to community experts in the field.
A list of the 29 current Interest Groups can be found at http://
www.geneontology.org/GO.interests.shtml.
GO content meetings serve to bring GO curators and bio-
logists together to resolve specific sub-trees of the GO struc-
ture. Many of the recent improvements in GO stem from the
first content meeting, held in August 2004, where members
of the GO group and domain experts in plant pathogens
(PAMGO), the cell cycle and metabolism participated.
PAMGO: a case study
The successful interaction between the PAMGO group and GO
curators provides a model that the GO Consortium will use to
involve research communities to cover a number of additional
topics in the future. The PAMGO Interest Group (http://
pamgo.vbi.vt.edu/) was formed in 2004 to develop new higher
level biological process terms for annotating gene products of
various microbes (bacteria, oomycetes, fungi and nematodes)
involved in pathogenic interactions with plants. Prior to the
August 2004 GO content meeting, the PAMGO group drafted
a set of high level terms to represent the range of host-microbe
interactions, from mutualism to parasitism, for any microbial
species and for animal as well as plant hosts. The proposal
generated intensive discussion during and after the GO
Content meeting, and three modified options were considered
at a GO Consortium meeting in October 2004. A final ‘tree’ of
terms, including 35 newly created terms, was resubmitted to
GO in December 2004 and incorporated into the ontology
structure in January 2005. The final set of terms is thus
a synthesis of PAMGO’s original submission and contribu-
tions from the GO Consortium, and the result of a process
that included broad-ranging discussion across the wider GO
community about the definitions of high level terms.
INCREASING ANNOTATION COVERAGE AND
QUALITY CONTROL
Alongside the development of GO ontology content, the use of
GO terms for gene product annotation has increased substan-
tially. Annotation data are now subject to checks to maintain
file format integrity and avoid redundancy, and GO Consor-
tium member groups are developing measures to assess the
accuracy and consistency of annotations made by different
individuals or groups [for example see (12,13)].
Furthermore, the GO Consortium has recently begun an
effort to actively support new groups seeking to use GO for
gene product annotation and to make the resulting annotation
data available to the public as part of the GO repository.
GO annotations are now available for over 30 genomes
[plus many additional species, including 261 proteomes, via
UniProt (14)], with recent additions including chicken and
several prokaryotes.
GO ANNOTATION CAMPS
This attention to annotation outreach has led the GO Consor-
tium to initiate a series of meetings devoted to GO annotation
practices. These meetings, known as ‘Annotation Camps’,
review and refine the approaches that the GO Consortium
now takes to improve the coverage, accuracy and precision
of GO annotation data. At the first Annotation Camp, held in
June 2004, GO Consortium members focused on developing
and maintaining consistent annotation practices within and
among groups. The second Annotation Camp, held in June
2005, was larger and open to non-members (about two-thirds
of the participants), and thus served to help educate people
unfamiliar with the GO system, as well as continuing to work
toward the consistency goals of the first Camp. Each Annota-
tion Camp introduced the basic organization of the GO and
covered a number of practical aspects of its use. A key compo-
nent of the Annotation Camps was the review of example
papers by working groups, to improve the consistency of
gene product annotation based on literature.
Table 1. Current status of GO
Biological process terms 9805
Molecular function terms 7076
Cellular component terms 1574
Sequence Ontology terms 963
Genomes with annotationa 30
Annotated gene products
Total 1 618 739
Electronic only 1 460 632
Manually curated 158 107
aExcludes annotations from UniProt, which represent 261 annotated proteomes.
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In addition to the Consortium-wide Annotation Camps,
some GO Consortium members, such as The Institute for
Genomic Research, run their own annotation courses and
make annotation tools publicly available; individual database
curators may also learn directly from ‘mentors’ with extensive
experience using the GO system.
SOFTWARE DEVELOPMENTS
The GO Consortium provides software tools to navigate, use
and manipulate the GO terms and annotations. Many new
features have been added to the Java-based editing tool
DAG-Edit (http://godatabase.org/dev/), and its successor,
OBO-Edit, is in beta testing. OBO-Edit adds support for
many of the advanced features of ontology languages, such
as OWL. GO and OBO-Edit are also closely coordinated with
the development of Obol, a formal language for specifying
ontology terms (15).
AmiGO (http://www.godatabase.org/cgi-bin/amigo/go.cgi)
is a web resource developed by the GO Consortium for search-
ing and browsing the Gene Ontology terms and gene product
annotations. Recent enhancements include expanded search-
ing of the ontology and gene products as well as improved
display of search results. Synonyms, which may include
phrases and terminology familiar to biologists and which
clarify the meanings of GO terms, are now included in the
GO term search and display. In addition, AmiGO now
searches all available gene and gene product names provided
by the annotation groups. The displays of search results and
annotation data have been improved, as shown in Figure 1.
APPLICATIONS OF GO DATA
In parallel with the growth of annotation coverage, GO’s
resources are now used in a number of different applications.
The GO Bibliography, a collection of peer-reviewed literature
on the development and usage of GO, has grown to over
600 publications (see http://www.geneontology.org/cgi-bin/
biblio.cgi), documenting a number of novel uses of GO.
GO and gene expression
Among the most widespread applications of GO data is the use
of GO terms and gene product annotations to help interpret the
results of large-scale experiments, such as microarrays, in
which any correlation between the functional information cap-
tured by GO and the expression patterns of a set of genes can
help to highlight underlying biological phenomena. A large
number of software tools have been developed to facilitate the
analysis of gene expression data using GO (for a partial list see
http://www.geneontology.org/GO.tools.microarray.shtml), and
a paper reviewing the relative merits of a subset of these
tools has recently been published (16).
GO terms and annotations have also been put to a variety of
other uses, in both the biological and computer science com-
munities. Biologists have used GO for tasks, such as gene
function prediction (17), collaborative construction and ana-
lysis of cellular pathways (18), and association of genes to
genetically inherited diseases (19). GO terms have also been
incorporated into the Unified Medical Language System
(UMLS) (20) maintained by the US National Library of
Medicine (21). In the computer science community, GO has
been used as a test of applying description logic (22,23)
approaches to building sound, complete and logically consist-
ent ontologies (22,24), and has featured in research into
machine-processable ontologies (25) and into the automated
checking of ontological consistency (26). Notably, GO terms
offer a valuable standardized terminological resource to nat-
ural language processing researchers, facilitating information
extraction from texts, knowledge discovery and ontology
building from large collections of documents. For example,
GO terms have been used in the Textpresso text mining system
and in the BioCreAtIvE text mining assessment (13,27,28).
The NCI cancer biomedical informatics grid (caBIG)
initiative and GO
The GO has been adopted by the caBIG initiative (https://
cabig.nci.nih.gov/), enabling the cancer community to analyze
microarray and proteomic data. Several available tools are
now being integrated into caBIG, including GOminer (29,30),
caArray, caWorkbench, RProteomics, Bioconductor (31),
Reactome (32) and the cancer Pathways Interaction Database.
In addition, caBIG has been integrating the Gene Ontology
into the NCI Metathesaurus, Enterprise Vocabulary System
and the cancer Data Standards Repository so that any caBIG
project, dataset, or tool can take advantage of the GO. The GO
has become the unifying terminology for the description and
annotation of biological process, localization and function of
gene products throughout the cancer research community.
ADDITIONAL ONTOLOGIES FOR BIOLOGY: OBO
The Gene Ontology is one of the ontologies held in the
Open Biomedical Ontologies (OBO) collection (http://obo.
sourceforge.net/). By providing controlled vocabularies that
are freely available, OBO aims to extend GO development
principles to many additional biological domains. There are
currently over 40 ontologies lodged in OBO, covering domains
such as anatomy, development, and phenotype, genomic and
proteomic information and taxonomic classification. In addi-
tion to GO, OBO includes a relationship types ontology and
the Sequence Ontology.
The OBO relationship types ontology (http://obo.
sourceforge.net/relationship/) is an ontology of core relation-
ship types, such as is_a, part_of, located_in and derives_from,
with explicit definitions, to be used by all ontologies in the
OBO collection (33).
SO: the Sequence Ontology
The Sequence Ontology (SO) provides terms and relationships
for describing the features and attributes of biological sequen-
ces, e.g. DNA, RNA and proteins. Its purpose is to promote the
standardization of sequence annotation among different organ-
isms (34). The ontology currently contains 963 terms and
16 relationship types. A subset of the terms and relationships
that describe located sequence features, known as SOFA
(Sequence Ontology Feature Annotation), have been selected
to provide a basic vocabulary to describe the products of
automatic genome annotation efforts. SOFA is in its second
release, and contains 179 terms. Ongoing development of both
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SO and SOFA proceeds via feedback and discussion from
the annotation community through a mailing list and through
soliciting the advice of domain experts.
The Sequence Ontology is primarily used to specify the type
of annotation features in flat files [e.g. GFF3 (10)] and data-
bases (e.g. CHADO, a relational database schema) (http://
song.sourceforge.net/so_compliant_formats.shtml). SO and
SOFA are currently being used to describe the annotations
of several model organism genomes, both by automated pipe-
line and manual curation (http://song.sourceforge.net/so_
groups.shtml). To facilitate integration with existing
genome annotation projects, SO terms have been mapped to
homologous terms in other biological vocabularies, such as the
MGED ontology (35) and the GenBank feature table (36).
These mappings are available on the web (http://song.
sourceforge.net/so_mappings.shtml).
THE FUTURE OF GO
Ontology content
Work on immunology and on responses to stimuli is planned,
and appropriate contacts are being made. The GO Consortium
Figure 1. Improved AmiGO interface. For all search results, the string matching the search query is highlighted to help identify why a specific result was returned.
(A) The gene product search result display has been expanded to provide hyperlinks to documentation, references and other databases that contain information that
support each annotation. Readability is greatly improved, such that for each search result, a sentence can be constructed from the tabular format, e.g. gene X from
species S is annotated to term Y based on evidence of type Z from publications A, B and C. (B) The term search now includes comments; the search result display
shows matches to synonyms as well as term names. Obsolete terms are grayed out and any suggested replacement terms are highlighted (data not shown).
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also hopes to tackle the areas of transport, signaling and
neurobiology in the near future.
Gene product annotation
The GO Consortium will continue to update existing annota-
tion datasets and work with new database groups that will
annotate more species. In addition, curators and software
developers will devise systems to enable bench scientists to
contribute annotations for their domains of expertise.
Software/AmiGO
Further development and enhancement of AmiGO will
make additional information about the organization of the
ontology available and provide more up-to-date access to the
annotations.
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